Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca L Porter

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Stem Cells (Dayton, Ohio)|November 22, 2012
Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injuryRebecca L Porter, Mary A Georger, Olga Bromberg, et al.
Blood|September 4, 2009
In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cellsBenjamin J Frisch, Rebecca L Porter, Benjamin J Gigliotti, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 12, 2026
Cell Culture Substrate Variation Alters Extracellular Vesicle Biogenesis Without Affecting Non-Coding Repeat RNA ProfileSara I Veiga, Rebecca L Porter, Berent Aldikacti, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2010
X-ray diffraction evidence for myosin-troponin connections and tropomyosin movement during stretch activation of insect flight muscleRobert J Perz-Edwards, Thomas C Irving, Bruce A J Baumann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2016
Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular GenotypingIbiayi Dagogo-Jack, Justin F Gainor, Rebecca L Porter, et al.
JCO Precision Oncology|January 20, 2022
Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation SequencingAdem Albayrak, Ana C Garrido-Castro, Marios Giannakis, et al.
Nature Communications|March 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trialRebecca L Porter, Yinglu Zhou, Nebiyat Eskndir, et al.
The Journal of Clinical Investigation|June 16, 2022
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotypeRebecca L Porter, Siyu Sun, Micayla N Flores, et al.
Science Advances|July 12, 2024
CAR memory-like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancerMubin Tarannum, Khanhlinh Dinh, Juliana Vergara, et al.
Cell|October 9, 2024
Disruption of cellular plasticity by repeat RNAs in human pancreatic cancerEunae You, Patrick Danaher, Chenyue Lu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Stem Cells (Dayton, Ohio)|November 22, 2012
Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injuryRebecca L Porter, Mary A Georger, Olga Bromberg, et al.
Blood|September 4, 2009
In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cellsBenjamin J Frisch, Rebecca L Porter, Benjamin J Gigliotti, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 12, 2026
Cell Culture Substrate Variation Alters Extracellular Vesicle Biogenesis Without Affecting Non-Coding Repeat RNA ProfileSara I Veiga, Rebecca L Porter, Berent Aldikacti, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2010
X-ray diffraction evidence for myosin-troponin connections and tropomyosin movement during stretch activation of insect flight muscleRobert J Perz-Edwards, Thomas C Irving, Bruce A J Baumann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2016
Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular GenotypingIbiayi Dagogo-Jack, Justin F Gainor, Rebecca L Porter, et al.
JCO Precision Oncology|January 20, 2022
Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation SequencingAdem Albayrak, Ana C Garrido-Castro, Marios Giannakis, et al.
Nature Communications|March 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trialRebecca L Porter, Yinglu Zhou, Nebiyat Eskndir, et al.
The Journal of Clinical Investigation|June 16, 2022
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotypeRebecca L Porter, Siyu Sun, Micayla N Flores, et al.
Science Advances|July 12, 2024
CAR memory-like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancerMubin Tarannum, Khanhlinh Dinh, Juliana Vergara, et al.
Cell|October 9, 2024
Disruption of cellular plasticity by repeat RNAs in human pancreatic cancerEunae You, Patrick Danaher, Chenyue Lu, et al.
Pageof 3